Authors: Reszka, AA Halasy-Nagy, J Rodan, GA

Citation: Aa. Reszka et al., Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation, MOLEC PHARM, 59(2), 2001, pp. 193-202

Authors: Fisher, JE Rodan, GA Reszka, AA

Citation: Je. Fisher et al., In vivo effects of bisphosphonates on the osteoclast mevalonate pathway, ENDOCRINOL, 141(12), 2000, pp. 4793-4796

Authors: Bergstrom, JD Bostedor, RG Masarachia, PJ Reszka, AA Rodan, G

Citation: Jd. Bergstrom et al., Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase, ARCH BIOCH, 373(1), 2000, pp. 231-241

Authors: Fisher, JE Rogers, MJ Halasy, JM Luckman, SP Hughes, DE Masarachia, PJ Wesolowski, G Russell, RGG Rodan, GA Reszka, AA

Citation: Je. Fisher et al., Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro, P NAS US, 96(1), 1999, pp. 133-138

Authors: Reszka, AA Halasy-Nagy, JM Masarachia, PJ Rodan, GA

Citation: Aa. Reszka et al., Bisphosphonates act directly on the osteoclast to induce caspase cleavage of Mst1 kinase during apoptosis - A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase, J BIOL CHEM, 274(49), 1999, pp. 34967-34973